Not a single study
Story checked
Common epilepsy medication and birth control combinations may reduce contraceptive effectiveness (opens in a new tab)
medicalxpress.com · 2026-10-07
Short answer
Not a single studyNo clear answer.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Common epilepsy medication and birth control combinations may reduce contraceptive effectiveness
medicalxpress.com · 2026-10-07
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
This story isn't reporting one study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Open claim evidenceSearch result
No single source study.
The article covers a research area rather than reporting a specific new paper, so there is no single study to check it against.
Source layer
The paper behind the story
The source record for this check.
The research anchor for the report.
- Also referencedpresented as the new finding
Contraceptive and Enzyme-Inducing Antiseizure Medication Co-Prescription Among U.S. Medicaid Beneficiaries with Epilepsy
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedNearly one-third of people with epilepsy who were prescribed certain hormonal contraceptives also received antiseizure medications that may make those contraceptives less effective, according to a University of Pittsburgh–led study published in Neurology.View evidenceHide evidence
As statednearly one-third
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 5Not checkedUsing U.S. Medicaid claims data, the researchers identified 110,976 people with epilepsy of childbearing potential receiving antiseizure medications, and nearly 1 in 5 had received a hormonal contraceptive that could be affected by enzyme-inducing antiseizure medications between 2018 and 2021.View evidenceHide evidence
As stated110,976 people; nearly 1 in 5
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 5Not checkedAmong those individuals, nearly one-third experienced at least one period of 14 days or longer when prescriptions for a susceptible contraceptive and an enzyme-inducing antiseizure medication overlapped, and the median duration of overlap was 218 days.View evidenceHide evidence
As statednearly one-third; 14 days or longer; median 218 days
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 5Not checkedPeople with intellectual disability had more than twice the odds of experiencing an overlap compared with people without intellectual disability, and those with drug-resistant epilepsy and those age 35 or older also had higher odds of overlap and longer periods of concurrent prescriptions.View evidenceHide evidence
As statedmore than twice the odds
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 5Not checkedThe article says not all contraceptive methods are affected; intrauterine devices, including hormonal and copper devices, are not affected by enzyme-inducing antiseizure medications.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref, Europe PMC · 15 candidate papers
Neurocysticercosis in California: Clinical Characteristics and Associated Comorbidities Across the University of California Health System.
medRxiv : the Preprint Server for Health Sciences · 2026 · PubMed
ABSTRACT NUMBER: ESOC2026YS41 EFFECT COMPARISON OF ENZYME INDUCING AGAINST NON ENZYME INDUCING ANTISEIZURE MEDICATIONS AS POTENTIAL CARDIOVASCULAR RISK FACTORS IN PEOPLE LIVING WITH EPILEPSY
European Stroke Journal · 2026 · Crossref
Outcomes after cardiac surgery in patients with epilepsy: A nationwide analysis.
2025 · Europe PMC
The Gatekeeper's Dilemma: Why Sustainable Functional/Dissociative Seizure Care Begins With Referral.
Neurology. Clinical Practice · 2026 · PubMed
Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits
Epilepsy Currents · 2022 · Crossref
And 10 more candidates considered.